BGLA

BIOGAIA AB B O.N.

€11.46+€0.01 (0.09%)

Estimate

P/E

32.7

EPS

0.35

Beta

0.273

Growth

Revenue, YoY

18.05%

Net income, YoY

26.15%

FCF, YoY

-49.13%

Dividends

Dividend yield

0.28%

Annual payout

SEK 0.36

Next ex. div date

May 8, 27

Payout

108.41%

Div.growth, 5y

55.87%

Div.rating

About the company

Ticker

BGLA

ISIN

SE0017769995

Country

Sweden

Sector (GICS)

Healthcare

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. Its Adult Health segment provides gut health tablets, bone health tablets, and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment offers packaging solutions. It sells its products through distribution partners or through its own distribution channels. The company was incorporated in 1990 and is headquartered in Stockholm, Sweden.

Frequently asked questions

What sector does BIOGAIA AB B O.N. (BGLA) operate in?

BIOGAIA AB B O.N. belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is BIOGAIA AB B O.N. (BGLA) current stock price?

As of the latest data, BIOGAIA AB B O.N. stock price is €11.46, with a previous close of €11.45. BIOGAIA AB B O.N. gained €0.01 in the last trading session, representing a 0.09% increase.

What is BIOGAIA AB B O.N. (BGLA) current market capitalization?

BIOGAIA AB B O.N. market cap is approximately 1.13 billion.

What is BIOGAIA AB B O.N. (BGLA) Earnings Per Share (EPS)?

The trailing EPS is €0.35.

What is BIOGAIA AB B O.N. (BGLA) Price-to-Earnings (P/E) ratio?

BIOGAIA AB B O.N. current P/E ratio is 32.74.

What is BIOGAIA AB B O.N. (BGLA) EBITDA?

BIOGAIA AB B O.N. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 12.64 million.

Does BIOGAIA AB B O.N. (BGLA) pay dividends?

Yes. BIOGAIA AB B O.N. pays annual dividends with an annualized yield of 0.28% and an estimated annual payout of €0.36 per share.

When is the next ex-dividend date for BIOGAIA AB B O.N. (BGLA)?

The next ex-dividend date is scheduled for May 08, 2027.

When is BIOGAIA AB B O.N. (BGLA) next earnings report?

BIOGAIA AB B O.N. is expected to release its next earnings report on September 30, 2026.

What is BIOGAIA AB B O.N. (BGLA) beta (volatility) score?

BIOGAIA AB B O.N. has a beta of 0.273, indicating lower volatility than the overall market.